May 9 (Reuters) - Imricor Medical Systems Inc (IMR) :
- VISABL-AFL TRIAL FOR US FDA APPROVAL RECEIVES FINAL APPROVAL AT LAUSANNE UNIVERSITY HOSPITAL IN SWITZERLAND
- VISABL-AFL IS ON SCHEDULE TO COMPLETE ALL REQUIRED PROCEDURES BY YEAR END
(([email protected];))
News: IMR Imricor Medical Systems Says Visabl-AFL Trial For Us FDA Approval Receives Final Approval
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.000(0.00%) |
Mkt cap ! $496.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4750 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.44 | 8900 | 1 |
View Market Depth
| Last trade - 08.02am 30/06/2025 (20 minute delay) ? |
| IMR (ASX) Chart |
Day chart unavailable